What is the current Price Target for the Kronos Bio Inc stock?

The average Kronos Bio Inc target price is $1.00. This is 25.00% higher than the current stock price. 1 Analyst has issued a Kronos Bio Inc price target 2026.

How high will the Kronos Bio Inc stock rise?

No reliable answer can be given as to how high the Kronos Bio Inc stock will rise. The performance of stocks, including the Kronos Bio Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Kronos Bio Inc stock today?

The performance of Kronos Bio Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Kronos Bio Inc stock fall?

The decline in Kronos Bio Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Kronos Bio Inc Forecast, price target & analysts

$0.80

4.31% yesterday

Nasdaq, Apr 03, 10:03 pm CET

ISIN

US50107A1043

Symbol

KRON

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Kronos Bio Inc Target price 2025 - Analyst rating & recommendation

Kronos Bio Inc Classifications & Recommendation:

Hold

100%

Kronos Bio Inc Price Target

Target Price	$1.00
Price	$0.80
Potential	25.00% register free of charge
Number of Estimates	1

	1 Analyst has issued a Kronos Bio Inc price target 2026. The average Kronos Bio Inc target price is $1.00. This is 25.00% register free of charge higher than the current stock price.
	A rating was issued by 2 analysts: 0 Analysts recommend Kronos Bio Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Kronos Bio Inc stock has an average upside potential 2026 of 25.00% register free of charge . Most analysts recommend the Kronos Bio Inc stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.43	-1.30
	26.67%	9.09%
P/E		negative

1 Analysts have issued a Kronos Bio Inc forecast for earnings per share. The average Kronos Bio Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.43	26.67%
2025	$-1.30 9.09% Unlock
2026	$-1.35 3.85% Unlock
2027	$-1.00 25.93% Unlock
2028	$-0.90 10.00% Unlock

Current	-0.56	16.42%
2025	-0.80 42.86% Unlock
2026	-0.77 3.75% Unlock
2027	-1.04 35.06% Unlock
2028	-1.16 11.54% Unlock

Kronos Bio Inc...

Current Kronos Bio Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Piper Sandler	Locked ➜ Locked	Locked	Nov 14 2024
TD Cowen	Locked ➜ Locked	Locked	Nov 14 2024
Piper Sandler	Locked ➜ Locked	Locked	Oct 08 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 19 2024

Analyst Rating	Date
Locked Piper Sandler: Locked ➜ Locked	Nov 14 2024
Locked TD Cowen: Locked ➜ Locked	Nov 14 2024
Locked Piper Sandler: Locked ➜ Locked	Oct 08 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 19 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now